The nuclear action of LOXL2 in the invasion and tumorigenesis of breast cancer cells is also mediated, at least in part, through the upregulation of the receptor activity-modifying protein 3 (RAMP3) gene, although the implication of RAMP3 in EMT has not been investigated yet [123]. Here, LOXL2 is linked to breast carcinoma.